文献速递耳科与耳神经

成人人工耳蜗的健康状态效用值:系统综述与网状Meta分析

Health State Utility Values Associated with Cochlear Implants in Adults: A Systematic Review and Network Meta-Analysis.
PubMed 文献 · Ear Hear · 2022-10-28

该系统综述与网状Meta分析检索MEDLINE、EMBASE、PsycINFO和Cochrane Library(截至2021年5月1日),纳入36项报告成人双侧至少中度至重度感音神经性听力损失患者接受单侧或双侧人工耳蜗的健康状态效用值(HSUV)研究。网状Meta分析显示,与植入前相比,单侧人工耳蜗HSUV平均变化+0.17(95%可信区间+0.12至+0.23),双侧+0.25(95%可信区间+0.12至+0.37);双侧与单侧相比差异无统计学意义(+0.08,95%可信区间-0.06至+0.21)。

要点

  • 单侧人工耳蜗较植入前HSUV平均变化+0.17(95%可信区间+0.12至+0.23)。
  • 双侧人工耳蜗较植入前HSUV平均变化+0.25(95%可信区间+0.12至+0.37)。
  • 双侧与单侧人工耳蜗HSUV差异无统计学意义(+0.08,95%可信区间-0.06至+0.21)。

核心结论

  • 本综述与网状Meta分析的结果构成成人人工耳蜗成本效用模型参数化的最佳可用资源,并强调需批判性评估现有HSUV工具在双侧人工耳蜗人群中的有效性。

研究设计与样本

  • 系统综述与贝叶斯网状Meta分析,纳入报告年龄≥18岁、双耳至少中度至重度感音神经性听力损失并接受单侧或双侧人工耳蜗的成人HSUV的观察性或实验性研究。
  • 检索MEDLINE、EMBASE、PsycINFO和Cochrane Library数据库至2021年5月1日,共纳入36项报告独特患者队列的研究。
  • 主要指标为HSUV的合并平均差,采用网状Meta分析比较单侧人工耳蜗与植入前、双侧人工耳蜗与植入前、双侧与单侧人工耳蜗。

主要发现

  • 健康效用指数3(HUI-3)是最常用的HSUV elicitation方法。
  • 网状Meta分析合并了19个植入前均值估计(1402例患者)、19个单侧人工耳蜗均值估计(1701例患者)和5个双侧人工耳蜗均值估计(83例患者)的HUI-3 HSUV。
  • 与植入前相比,单侧人工耳蜗HSUV平均变化+0.17(95%可信区间+0.12至+0.23)。
  • 与植入前相比,双侧人工耳蜗HSUV平均变化+0.25(95%可信区间+0.12至+0.37)。
  • 双侧与单侧人工耳蜗相比,HSUV差异无统计学意义(+0.08,95%可信区间-0.06至+0.21)。

关键数值与推荐

  • HSUV为锚定于0(死亡状态)和1(完美健康)的健康相关生活质量单一数值总结。
  • 与植入前相比,单侧人工耳蜗HSUV平均变化+0.17(95%可信区间+0.12至+0.23)。
  • 与植入前相比,双侧人工耳蜗HSUV平均变化+0.25(95%可信区间+0.12至+0.37)。
  • 双侧与单侧人工耳蜗相比,HSUV差异无统计学意义(+0.08,95%可信区间-0.06至+0.21)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 总体研究质量为中等。
  • 作者结论强调需批判性评估现有HSUV工具在双侧人工耳蜗人群中的有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The cost-effectiveness of bilateral cochlear implants in adults remains uncertain despite established clinical benefits. In cost-effectiveness studies, benefit is often measured by change in health state utility value (HSUV), a single number summary of health-related quality of life anchored at 0 (state of being dead) and 1 (perfect health). Small differences in bilateral cochlear implant HSUV change conclusions of published models, and invalid estimates can therefore mislead policy and funding decisions. As such, we aimed to review and synthesize published HSUV estimates associated with cochlear implants. DESIGN: We included observational or experimental studies reporting HSUV for adult patients (age ≥18 years) with at least moderate-profound sensorineural hearing loss in both ears who received unilateral or bilateral cochlear implants. We searched MEDLINE, EMBASE, PsycINFO, and Cochrane Library databases up to May 1, 2021. Study and participant characteristics and HSUV outcomes were extracted. Narrative synthesis is reported for all studies. A Bayesian network meta-analysis was conducted to generate pooled estimates for the mean difference in HSUV for three comparisons: (1) unilateral cochlear implant versus preimplant, (2) bilateral cochlear implants versus preimplant, (3) bilateral versus unilateral cochlear implants. Our principal measure was pooled mean difference in HSUV. RESULTS: Thirty-six studies reporting unique patient cohorts were identified. Health Utilities Index, 3 (HUI-3) was the most common HSUV elicitation method. HSUV from 19 preimplant mean estimates (1402 patients), 19 unilateral cochlear implant mean estimates (1701 patients), and 5 bilateral cochlear implants mean estimates (83 patients) were pooled to estimate mean differences in HUI-3 HSUV by network meta-analysis. Compared with preimplant, a unilateral cochlear implant was associated with a mean change in HSUV of +0.17 (95% credible interval [CrI] +0.12 to +0.23) and bilateral cochlear implants were associated with a mean change of +0.25 (95% CrI +0.12 to +0.37). No significant difference in HSUV was detected for bilateral compared with unilateral cochlear implants (+0.08 [95% CrI -0.06 to +0.21]). Overall study quality was moderate. CONCLUSIONS: The findings of this review and network meta-analysis comprise the best-available resource for parameterization of cost-utility models of cochlear implantation in adults and highlight the need to critically evaluate the validity of available HSUV instruments for bilateral cochlear implant populations.Protocol registration: PROSPERO (CRD42018091838).

来源:Ear Hear,查看原文。版权归原作者所有。

引用

  1. Dixon PR, Shapiro J, Tomlinson G, et al. Health State Utility Values Associated with Cochlear Implants in Adults: A Systematic Review and Network Meta-Analysis. Ear Hear. 2022. PMID: 36303282. doi:10.1097/AUD.0000000000001287

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。